German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Regeneron Pharmaceuticals

Market Cap: €67.6b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Grand Pharmaceutical Group

Market Cap: €17.8b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Perrigo

Market Cap: €1.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Indivior Pharmaceuticals

Market Cap: €4.9b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Regeneron Pharmaceuticals

Market Cap: €67.6b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Prestige Consumer Healthcare

Market Cap: €2.3b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Collegium Pharmaceutical

Market Cap: €1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Faes Farma

Market Cap: €1.4b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.

Trajan Group Holdings

Market Cap: €44.3m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

United Laboratories International Holdings

Market Cap: €18.0b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Virbac

Market Cap: €2.7b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

Bavarian Nordic

Market Cap: €14.0b

Develops, manufactures, and supplies life-saving vaccines.

ANI Pharmaceuticals

Market Cap: €1.7b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

3SBio

Market Cap: €45.2b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

China Medical System Holdings

Market Cap: €28.8b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €210.3m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

China Resources Pharmaceutical Group

Market Cap: €28.3b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Bausch Health Companies

Market Cap: €1.8b

Operates as a diversified specialty pharmaceutical and medical device company.

Cresco Labs

Market Cap: €490.5m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

CorMedix

Market Cap: €659.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Consun Pharmaceutical Group

Market Cap: €11.4b

Produces and sells pharmaceutical products in Mainland China.

Bavarian Nordic

Market Cap: €14.0b

Develops, manufactures, and supplies life-saving vaccines.

Vetoquinol

Market Cap: €825.2m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

High Tide

Market Cap: €274.2m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Teva Pharmaceutical Industries

Market Cap: €38.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Eurofins Scientific

Market Cap: €12.1b

Provides various analytical testing and laboratory services worldwide.

Gossamer Bio

Market Cap: €83.0m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.

Viatris

Market Cap: €18.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

ACADIA Pharmaceuticals

Market Cap: €4.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Bayer

Market Cap: €49.2b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Protara Therapeutics

Market Cap: €242.8m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Daiichi Sankyo Company

Market Cap: €4.9t

Manufactures and sells pharmaceutical products in Japan and internationally.

Novartis

Market Cap: €227.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Fortrea Holdings

Market Cap: €1.7b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.